Tag Archives: Favipiravir

Fujifilm to Develop AI-based Technology to Aid COVID-19-Induced Pneumonia Diagnosis and Assess The Effectiveness of Treatments

Fujifilm to Develop AI-based Technology to Aid COVID-19-Induced Pneumonia Diagnosis and Assess The Effectiveness of Treatments Company commences joint research study with leading medical institutions in Japan, applying lesion quantification technology for pneumonia TOKYO, May 19, 2020 — FUJIFILM Corporation (President: Kenji Sukeno) is commencing a research study to develop Artificial Intelligence (AI)-based technology to […]

Posted in Press releases | Also tagged , , , | Leave a comment

Japan Sent Fujifilm’s Favipiravir (Avigan) to 43 Countries For COVID-19 Trials

We have been following Fujifilm Avigan (Favipiravir) and COVID-19 involvement for a while ( 1, 2, 3, 4, 5, 6, 7, 8, 9, 10. 11, 12, 13) and trials keep coming up with positive results. It is now being reported that Fujifilm is sharing their “wonder drug” via the Japanese Government with 43 countries for approval in the treatments of COVID-19 via the United Nations Office for […]

Posted in Press releases | Also tagged , , , | Leave a comment

Fujifilm Develops New PCR COVID-19 Quick Test

Translated Notification of application of public medical insurance to the new gene detection kit “SARS-CoV-2 RT-qPCR Detection kit” for coronavirus that greatly shortens PCR test time (Fujifilm Wako Pure Chemical) FUJIFILM Wako Pure Chemical Industries, Ltd. (Head office: Chuo-ku, Osaka, President: Kazuo Shiraki) has announced that the research reagent “SARS-CoV-2 RT-qPCR Detection kit” released on April 15 […]

Posted in Press releases | Also tagged , , , | Leave a comment

Fujifilm Teams With COVID-19 Therapeutics Accelerator to Reserve Manufacturing Capacity And Provide Technical Expertise to Deliver Future COVID-19 Therapies

FUJIFILM Diosynth Biotechnologies teams with COVID-19 Therapeutics Accelerator to reserve manufacturing capacity and provide technical expertise to deliver future COVID-19 therapies HILLERØD, Denmark, April 30, 2020 – FUJIFILM Diosynth Biotechnologies, a world leading biologics-Contract Development and Manufacturing Organization (CDMO), today announced that it will reserve manufacturing capacity for a future COVID-19 therapy for the COVID-19 […]

Posted in Press releases | Also tagged , , , | Leave a comment

Fujifilm Notice of the Postponement of Announcement of Financial Results Due To COVID-19

Notice of the Postponement of Announcement of Financial Results (Consolidated) for the Fiscal Year ended March 31, 2020 FUJIFILM Holdings Corporation (the “Company”) would like to express our deepest sympathy to all those who lost loved ones and those affected by COVID-19. Since it will take more time than we expected to close consolidated financial […]

Posted in Press releases | Also tagged , , , | Leave a comment

CMIC Group Supports Clinical Trials and Manufacturing of Influenza Antiviral Drug “Avigan® Tablet”

CMIC Group Supports Clinical Trials and Manufacturing of Influenza Antiviral Drug “Avigan® Tablet” and Contributes to Accelerating Provision for COVID-19 Patients TOKYO–(BUSINESS WIRE)–CMIC HOLDINGS Co., Ltd. (Head Office: Tokyo, Minato-ku, Representative Director & CEO Kazuo Nakamura, hereafter “CMIC”) announced today that CMIC is providing monitoring services as a CRO (Contract Research Organization) for “Avigan® Tablet” (generic […]

Posted in Press releases | Also tagged , , , | Leave a comment